NO940580D0 - Fremgangsmåte for å senke blodlipidnivåer - Google Patents

Fremgangsmåte for å senke blodlipidnivåer

Info

Publication number
NO940580D0
NO940580D0 NO940580A NO940580A NO940580D0 NO 940580 D0 NO940580 D0 NO 940580D0 NO 940580 A NO940580 A NO 940580A NO 940580 A NO940580 A NO 940580A NO 940580 D0 NO940580 D0 NO 940580D0
Authority
NO
Norway
Prior art keywords
procedure
blood lipid
lowering blood
lipid levels
levels
Prior art date
Application number
NO940580A
Other languages
English (en)
Other versions
NO940580L (no
Inventor
Georges H Van Der Berghe
Harry Edward Gruber
Original Assignee
Gensia Inc
Gensia Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gensia Inc, Gensia Pharma filed Critical Gensia Inc
Publication of NO940580D0 publication Critical patent/NO940580D0/no
Publication of NO940580L publication Critical patent/NO940580L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO940580A 1991-08-23 1994-02-21 Fremgangsmåte for å senke blodlipidnivåer NO940580L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74894491A 1991-08-23 1991-08-23
US92975292A 1992-08-12 1992-08-12
PCT/US1992/006828 WO1993003734A1 (en) 1991-08-23 1992-08-14 Method for lowering blood lipid levels

Publications (2)

Publication Number Publication Date
NO940580D0 true NO940580D0 (no) 1994-02-21
NO940580L NO940580L (no) 1994-04-25

Family

ID=27115023

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940580A NO940580L (no) 1991-08-23 1994-02-21 Fremgangsmåte for å senke blodlipidnivåer

Country Status (7)

Country Link
EP (1) EP0599987A4 (no)
AU (1) AU2486192A (no)
CA (1) CA2115675A1 (no)
IL (1) IL102895A0 (no)
MX (1) MX9204880A (no)
NO (1) NO940580L (no)
WO (1) WO1993003734A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1492564A2 (en) * 2001-10-31 2005-01-05 Université Libre de Bruxelles Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents
ES2192495B1 (es) 2002-03-21 2005-02-16 Universidad De Barcelona Nuevo uso terapeutico del ribosido de 5-aminoimidazol-4-carboxamida (acadesina).
US8895520B2 (en) 2011-10-26 2014-11-25 Universite Nice Sophia Antipolis Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide
DK3050567T3 (da) * 2013-09-26 2021-02-08 Energenesis Biomedical Co Ltd Forbindelse til aktivering af ampk og anvendelser deraf
CA3107170A1 (en) 2018-08-06 2020-03-12 Skylark Bioscience Llc Amp-activated protein kinase activating compounds and uses thereof
US11779590B2 (en) 2020-10-30 2023-10-10 Skylark Bioscience Llc AMP-activated protein kinase activating compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2026040C3 (de) * 1970-05-27 1975-09-18 Boehringer Mannheim Gmbh, 6800 Mannheim Imidazolribosylcyclophosphate
US3919192A (en) * 1972-05-22 1975-11-11 Icn Pharmaceuticals 5-Amino-4-substituted imidazole nucleotides
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells

Also Published As

Publication number Publication date
WO1993003734A1 (en) 1993-03-04
CA2115675A1 (en) 1993-03-04
EP0599987A4 (en) 1995-02-01
IL102895A0 (en) 1993-01-31
AU2486192A (en) 1993-03-16
EP0599987A1 (en) 1994-06-08
NO940580L (no) 1994-04-25
MX9204880A (es) 1993-04-01

Similar Documents

Publication Publication Date Title
DK0547901T3 (da) Hejseapparater til patienter
FI923273A (fi) Med dubbelminne foersett multiprocessorsystem
DE69211359D1 (de) Blutbehälter
DE69217375T2 (de) Bestimmungsverfahren
ITMI921590A0 (it) Benzofuran-2-oni tiemetilati
DE69124516T2 (de) Katheter
DE69131050D1 (de) Chirurgische aufnahmevorrichtung
DE69215639D1 (de) Endoskop
FI942972A0 (fi) Kattoon upotettava vuode- tai makuulaverirakenne
FR2688695B1 (fr) Matelas medical.
NO914995D0 (no) Sammenleggbar rullestol
DE69213572D1 (de) Hospitalgewebe
NO940580L (no) Fremgangsmåte for å senke blodlipidnivåer
NO924040D0 (no) Rullestol
NO954147L (no) Forbedringer vedrörende pasientheiser
ATA151691A (de) Krankenfahrstuhl
FR2626467B1 (fr) Matelas medical
NO922488D0 (no) Rullestol
DE9219024U1 (de) Rollstuhl
KR930006241U (ko) 환자용 벼개
KR950003044U (ko) 환자용 침대
ES1018174Y (es) Cama clinica.
KR920017579U (ko) 매트리스
NO302508B1 (no) Rullestol
SE9102036D0 (sv) Foerfarande foer rippelreducering